Mesenchymal stem cells and conditioned media in the treatment of multiple sclerosis patients: Clinical, ophthalmological and radiological assessments of safety and efficacySaid Dahbour, Abdalla Awidi, Ammar Huneiti et al.|CNS Neuroscience & Therapeutics|2017Cited by 123
Human Umbilical Cord–Derived Mesenchymal Stem Cells in the Treatment of Multiple Sclerosis Patients: Phase I/II Dose-Finding Clinical StudyFatima Jamali, Abdalla Awidi, Mayis Aldughmi et al.|Cell Transplantation|2024Cited by 25
A New Tool for Safety Evaluation and a Combination of Measures for Efficacy Assessment of Cotransplanting Human Allogenic Neuronal Stem Cells and Mesenchymal Stem Cells for the Treatment of Parkinson Disease: Protocol for an Interventional StudyFatima Jamali, Abdalla Awidi, Mayis Aldughmi et al.|JMIR Research Protocols|2021Cited by 8
Safety and Efficacy of Bone Marrow and Adipose Tissue Mesenchymal Stem Cells in the Treatment of Spinal Cord Injury: A Preliminary StudyFatima Jamali, Abdalla Awidi, Mahmoud Quda et al.|Jordan Medical Journal|2024Cited by 1
A New Tool for Safety Evaluation and a Combination of Measures for Efficacy Assessment of Cotransplanting Human Allogenic Neuronal Stem Cells and Mesenchymal Stem Cells for the Treatment of Parkinson Disease: Protocol for an Interventional Study (Preprint)Fatima Jamali, Abdalla Awidi, Mayis Aldughmi et al.|Unknown|2021Cited by 0